Literature DB >> 16115861

Pivotal role of Akt activation in mitochondrial protection and cell survival by poly(ADP-ribose)polymerase-1 inhibition in oxidative stress.

Antal Tapodi1, Balazs Debreceni, Katalin Hanto, Zita Bognar, Istvan Wittmann, Ferenc Gallyas, Gabor Varbiro, Balazs Sumegi.   

Abstract

According to the classical view, the cytoprotective effect of inhibitors of poly(ADP-ribose)polymerase (PARP) in oxidative stress was based on the prevention of NAD+ and ATP depletion, thus the attenuation of necrosis. Our previous data on PARP inhibitors in an inflammatory model suggested that PARP-catalyzed ADP-ribosylations may affect signaling pathways, which can play a significant role in cell survival. To clarify the molecular mechanism of cytoprotection, PARP activity was inhibited pharmacologically by suppressing PARP-1 expression by a small interfering RNA (siRNA) technique or by transdominantly expressing the N-terminal DNA-binding domain of PARP-1 (PARP-DBD) in cultured cells. Cell survival, activation of the phosphatidylinositol 3-kinase (PI3-kinase)/Akt system, and the preservation of mitochondrial membrane potential were studied in hydrogen peroxide-treated WRL-68 cells. Our data showed that suppression of the single-stranded DNA break-induced PARP-1 activation by pharmacological inhibitor, siRNA, or by the transdominant expression of PARP-DBD protected cells from oxidative stress and induced the phosphorylation and activation of Akt. Furthermore, prevention of Akt activation by inhibiting PI3-kinase counteracted the cytoprotective effect of PARP inhibition. Microscopy data showed that PARP inhibition-induced Akt activation was responsible for protection of mitochondria in oxidative stress because PI3-kinase inhibitors diminished the protective effect of PARP inhibition. Similarly, Src kinase inhibitors, which decrease Akt phosphorylation, also counteracted the protection of mitochondrial membrane potential supporting the pivotal role of Akt in cytoprotection. These data together with the finding that PARP inhibition in the absence of oxidative stress induced the phosphorylation and activation of Akt indicate that PARP inhibition-induced Akt activation is dominantly responsible for the cytoprotection in oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16115861     DOI: 10.1074/jbc.M507075200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

1.  Nebulization with γ-tocopherol ameliorates acute lung injury after burn and smoke inhalation in the ovine model.

Authors:  Yusuke Yamamoto; Perenlei Enkhbaatar; Linda E Sousse; Hiroyuki Sakurai; Sebastian W Rehberg; Sven Asmussen; Edward R Kraft; Charlotte L Wright; Eva Bartha; Robert A Cox; Hal K Hawkins; Lillian D Traber; Maret G Traber; Csaba Szabo; David N Herndon; Daniel L Traber
Journal:  Shock       Date:  2012-04       Impact factor: 3.454

2.  Thioredoxin-interacting protein mediates nuclear-to-plasma membrane communication: role in vascular endothelial growth factor 2 signaling.

Authors:  Oded N Spindel; Chen Yan; Bradford C Berk
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-02-16       Impact factor: 8.311

3.  Vulnerabilities of PTEN-TP53-deficient prostate cancers to compound PARP-PI3K inhibition.

Authors:  Enrique González-Billalabeitia; Nina Seitzer; Su Jung Song; Min Sup Song; Akash Patnaik; Xue-Song Liu; Mirjam T Epping; Antonella Papa; Robin M Hobbs; Ming Chen; Andrea Lunardi; Christopher Ng; Kaitlyn A Webster; Sabina Signoretti; Massimo Loda; John M Asara; Caterina Nardella; John G Clohessy; Lewis C Cantley; Pier Paolo Pandolfi
Journal:  Cancer Discov       Date:  2014-05-27       Impact factor: 39.397

4.  Tankyrase recruitment to the lateral membrane in polarized epithelial cells: regulation by cell-cell contact and protein poly(ADP-ribosyl)ation.

Authors:  Tsung-Yin J Yeh; Tobias N Meyer; Catherine Schwesinger; Zhi-Yang Tsun; Ray M Lee; Nai-Wen Chi
Journal:  Biochem J       Date:  2006-11-01       Impact factor: 3.857

5.  Thrombotic thrombocytopenic purpura and defective apoptosis due to CASP8/10 mutations: the role of mycophenolate mofetil.

Authors:  F Fioredda; E Cappelli; A Mariani; A Beccaria; E Palmisani; A Grossi; I Ceccherini; R Venè; C Micalizzi; M Calvillo; F Pierri; I Mancini; F Peyvandi; F Corsolini; C Dufour; M Miano
Journal:  Blood Adv       Date:  2019-11-12

Review 6.  Signaling mechanism of poly(ADP-ribose) polymerase-1 (PARP-1) in inflammatory diseases.

Authors:  Xueqing Ba; Nisha Jain Garg
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

7.  Facilitation of mitochondrial outer and inner membrane permeabilization and cell death in oxidative stress by a novel Bcl-2 homology 3 domain protein.

Authors:  Andras Szigeti; Eniko Hocsak; Edit Rapolti; Boglarka Racz; Arpad Boronkai; Eva Pozsgai; Balazs Debreceni; Zita Bognar; Szabolcs Bellyei; Balazs Sumegi; Ferenc Gallyas
Journal:  J Biol Chem       Date:  2009-11-09       Impact factor: 5.157

8.  Combined effect of protein kinase B inhibitor or extracellular signal-regulated kinase inhibitor against farnesyltransferase inhibition-induced apoptosis in SiHa cells.

Authors:  Sun Joo Lee; Chung Soo Lee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-10-15       Impact factor: 3.000

9.  Poly (ADP-ribose) synthetase inhibitor has a heart protective effect in a rat model of experimental sepsis.

Authors:  Lianshuang Zhang; Jinpeng Yao; Xifeng Wang; Hongxing Li; Tongshen Liu; Wei Zhao
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

10.  Upregulation of Salmonella-induced IL-6 production in Caco-2 cells by PJ-34, PARP-1 inhibitor: involvement of PI3K, p38 MAPK, ERK, JNK, and NF-kappaB.

Authors:  Fu-Chen Huang
Journal:  Mediators Inflamm       Date:  2010-02-24       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.